USA Rare Earth Stock Is Down 60% -- Is September the Month to Buy the Dip?

USA Rare Earth shares trade at $17.66, roughly 54% below their $43.98 October 2025 peak, following its March 2026 SPAC listing. The pre-revenue company acquired Brazil's Serra Verde for $2.8B, primarily through stock issuance, adding the Western Hemisphere's only scaled producer of dysprosium, neodymium, praseodymium and terbium. U.S. government investment and financing/purchase support bolster its strategic role in reducing reliance on Chinese rare-earth supply, but dilution, execution risk and high volatility make the stock suitable only for risk-tolerant investors.

Analysis

USAR’s investable question is not rare-earth demand but whether its equity can finance an integrated mine-to-magnet strategy without repeated dilution. Stock-funded M&A lowers near-term balance-sheet strain but transfers execution risk into the share count; absent a disclosed pro forma production, capex, debt and dilution schedule, the equity cannot be valued on conventional EV/EBITDA or FCF metrics. Government support is strategically valuable, but purchase commitments and financing support should be discounted until contract volumes, pricing floors, milestones and any warrant economics are public.

The more immediate competitive beneficiary of Western supply-chain policy may be MP Materials (MP), which has a more established public-market record and offers investors a cleaner way to express domestic rare-earth scarcity. USAR’s Brazilian operating exposure also introduces country, permitting, logistics and FX risks that a "US strategic minerals" narrative can obscure; any disruption would tighten ex-China supply and potentially benefit MP and Lynas (LYC.AX/LYSCF) rather than USAR. In the next 1-3 months, merger accounting, share-registration/lockup dynamics and pro forma disclosures are likely to matter more than commodity commentary.

Contrarian view: the drawdown alone is not evidence of an asymmetric entry point when the starting valuation was established in a thinly traded pre-merger vehicle. The upside case is real if contracted volumes convert into visible revenue and project funding is largely non-dilutive, but the market may still be underestimating the capex and time required to monetize separated rare-earth output. Over 6-18 months, a credible production ramp and binding offtakes could justify a strategic premium; a lower guidance range, incremental equity issuance, or delayed commissioning would likely compress that premium sharply.

Key Decisions for Investors

• Do not initiate a core USAR long before the next filing provides pro forma share count, net debt, capex, production ramp and terms of government-linked support. Treat confirmation of limited incremental equity needs as the entry trigger; a material share-count increase or commissioning delay falsifies the thesis.
• For a liquid strategic-minerals allocation over 6-12 months, prefer MP over USAR until USAR publishes independently auditable operating metrics. The relative trade is long MP / short USAR only for high-risk books and only after confirming USAR borrow availability and corporate-action dates; cover if USAR secures fixed-price offtakes or non-dilutive project financing.
• Set an event watch for SEC registration statements, lockup expirations, PIPE/share resale filings and the first post-acquisition operating update over the next 1-3 months. These events can create forced supply and are more actionable for entry timing than broad geopolitical headlines.
• If USAR discloses a fully funded ramp with contracted pricing, use a small staged long rather than a full position: initiate after the disclosure, add only following the first on-plan quarterly production report, and cap downside at a 25% loss from weighted entry given the binary dilution and execution risk.